PIK3CA and breast neoplasm: Notably, Kalinsky and colleagues showed in a series of 509 primary breast tumors with a median follow-up of more than 12 years that patients with PIK3CA-mutated tumors had a less aggressive phenotype with a significant improvement in OS and CSS 46.